essential medicines in sear
play

essential medicines in SEAR Kathleen A Holloway Regional Adviser - PowerPoint PPT Presentation

Improving access to, and use of, essential medicines in SEAR Kathleen A Holloway Regional Adviser Essential Medicines WHO/SEARO March 2016 | RA-EDM Presentation | March 31, 2016 Drug availability in public sector: - S. E. Asia Country %


  1. Improving access to, and use of, essential medicines in SEAR Kathleen A Holloway Regional Adviser Essential Medicines WHO/SEARO March 2016 | RA-EDM Presentation | March 31, 2016

  2. Drug availability in public sector: - S. E. Asia Country % Avail % drug Av. no. % prescr- Pharmacists *data from MOH Key Ess stock- drugs / ibed drugs always avail. N=10-20 drugs out patient dispensed above PHCs Bangladesh 2014 43-75 9-52 1.8-2.3 65-96 No Bhutan 2015 94-98 2-5 1.9-2.8 96-100 Yes DPR Korea 2012 - - 1.3-2.6 - ? Rajasthan 2013 - - 3.3-4.1 92-100 ? Karnataka 2013 89 24 3.2-3.6 92-100 No Indonesia 2011 - - 2.6-3.3 91-99 No Maldives 2014 - 6-21 3.0-3.4 87-90 No Myanmar 2014 59-80 18-24 2.2-3.3 - No Nepal 2014 68-82 21-38 2.3-2.8 78-93 No Sri Lanka 2015 72-79 3-7 2.8-3.6 92-99 No Thailand 2015 69-97 1-9 2.8-3.6 100 Yes | Timor-Leste 2015 RA-EDM Presentation | March 31, 2016 54-77 9-41 2.3-2.6 94-99 No

  3. Causes of stock-out  Bhutan: stock-out due to simultaneous policy changes – Regulation on non-importation of unregistered drugs enforced, – Anti-corruption Task Force, Audit Commission, & Min. of Finance misunderstanding about higher prices for better supplier criteria – “Encouraged” local wholesalers by 3-year tenders & higher default rates – For some products: no bids, no supplier & stock-out – Resolved after situational analysis & 2 nd policy meeting  Sri Lanka: stock-out due to quality problems – NRA registration process weak - few qual. staff, not following SOP – registration with the NRA is the only quality criteria in govt. purchase – 800 samples tested last year with 30% failure rate leading to withdrawal of 12 products overall and several batches every month & therefore stock-out – New NMRA established, & new e-LMIS introduced to monitor consumption | RA-EDM Presentation | March 31, 2016

  4. Unexpected consequences of price control for essential medicines  India: – different formulations and combinations manufactured to escape price control. • Irrational combinations • Paracetamol 650mg instead of 500mg • Labelling insufficient to alert public to dangers  Bangladesh: – National Essential Medicines List not revised (due to industry pressure according to respondents) • Only 209 medicines in the EML and so hospitals have to procure non-EML drugs | RA-EDM Presentation | March 31, 2016

  5. Public PHC AB use & stewardship – S.E. Asia Country % OPD % URTI Nat AMR DTCs ABs Pub educ. N=10-20 given given strategy most OTC on ABs in AB AB hos. last 2 yrs Bangladesh 2014 19-54 59-60 No No Yes No Bhutan 2015 33-49 26-42 No Rf hos Yes No DPR Korea 2012 18-51 58-81 No No Yes Not on AB Rajasthan 2013 53-67 81-100 No Yes Yes No Karnataka 2013 23-45 67-78 No No Yes No Indonesia 2011 34-55 72 2011 Yes Yes Yes Maldives 2014 15-34 33-48 No No Yes No Myanmar 2014 34-53 73-96 No No Yes No Nepal 2014 40-48 63-71 2001 Rf hos Yes No Sri Lanka 2015 45-67 47-85 No Yes Yes Not on AB Thailand 2015 11-14 20-52 2011 Yes Yes Not on AB Timor-Leste 2015 33-50 46-66 No No Yes No | RA-EDM Presentation | March 31, 2016

  6. Public PHC antibiotic use – S.E. Asia Country % OPD given AB % URTI given AB Policies implemented (10-20 between 2010-12 and 2010- 2014- 2010- 2014- facilities/ 2014-15 2012 2015 2012 2015 country) Bangladesh 34-74 19-54 - 59-60 No monitoring, no DTCs, no updated EML or STG Bhutan 31-34 33-49 - 26-42 Some monitoring & CME, updated EML & STGs Maldives 35-43 15-34 - 33-48 Decreased availability Myanmar 27-56 34-53 72-100 73-96 Increased availability Nepal 21-54 40-48 72-74 63-71 NGO RUM project in a few districts Sri Lanka 49 45-67 - 47-85 DTCs just started Thailand 23-45 11-14 54-62 20-52 Monitoring, updated EML, DTCs, AB Smart use proj. | Timor-Leste RA-EDM Presentation | March 31, 2016 42-75 33-50 69-88 46-66 Decreased availability

  7. Health worker views  Nurse in Timor-Leste – I order double what I need because they only send half what I order.  HP in Charge (Senior AHW) in Nepal – For children under 5 years with pneumonia I must give amoxycillin according to the IMCI guidelines. Since we are short of amoxycillin and have short-dated chloramphenicol syrup, I am prescribing chloramphenicol syrup to children of more than 5 years with pneumonia in order to use up the stock.  Pharmacy Technician in Bhutan – There is a lot of irrational prescribing by doctors but it is very difficult to give any feedback.  Doctor in Bangladesh – How can I make a proper diagnosis in one minute ? | RA-EDM Presentation | March 31, 2016

  8. Role of pharmacists  Pharmacists are needed to: – to manage the medicines supply system at all levels of the health sector – To undertake the monitoring of medicines use  Pharmacists in the public sector were: – Lacking at some levels of the health sector in Bangladesh, Karnataka (India), Indonesia, Myanmar, Maldives, Nepal, Sri Lanka, Timor-Leste – Present in Thailand and Bhutan where medicines management is significantly better | RA-EDM Presentation | March 31, 2016

  9. Summary  Access to medicines depends on many health system issues – Monitoring of many things • Availability, prices, compliance with essential medicines list, prescribing, dispensing, quality of medicines, regulation enforcement and policy implementation – Coherent coordinated policy making at the centre between different departments of MOH and also Ministries of Finance, Trade, Industry – Adequate procurement policies and regulation to ensure medicines quality – Adequate human resources, especially pharmacists, and a functional logistic management information system – Implementation of policies to promote appropriate use of medicines | RA-EDM Presentation | March 31, 2016

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend